Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 17 2020

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 17, 2020, titled "Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases